The SeVA platform is a composite AI device that can be effectively deployed in hospital, nursing homes and home settings. It has the capability to track a patient’s mental and physical state and signal early signs of risks such as delirium, falls or impending illness. It provides emotional support to the patient and their family by indulging in a natural conversation and facilitating their needs. When fully deployed, the product can serve as a platform which allays worry for people and their caregivers and will reduce healthcare costs by identifying the early signs of severe illness.

Aquaculture is the fastest growing food production sector in the world yet suffers 10% annual losses due to diseases (that’s ~$25 billion lost). Tools for control of these diseases are insufficient or too expensive. Efficacious and inexpensive solutions to address aquaculture disease are an industry priority. Our viral vector platform can be a solution – flexible and customizable to address finfish and crustacean diseases. It can be delivered orally to lower cost and make it more universally applicable to the industry.

We offer a novel tool for antibiotic treatment. Our approach targets a broad spectrum of bacteria but eliminates the risk of evolving resistance by targeting a multitude of pathways.

We have discovered new class of therapeutics that reduce the rate of cell growth in cancer and vascular lung diseases.

Safe Lactobacillus-based synthetic biologic as a colonization resistance agent of, and oral vaccine for, Clostridioides difficile infection (CDI).

Mastering surgical skills shouldn’t come at the cost of animals, high expenses, or limited training access. 3R SIMULATION reshapes animal surgical training with hyper-realistic simulators, offering a cost-effective, ethical, and accessible alternative to traditional methods. Our product enables professionals to hone skills anytime, anywhere, without sacrificing results. As demand for animal-free training grows, we are leading the shift towards a smarter, more responsible future in animal surgery education.

Many cancer drugs suffer from severe adverse effects due to acute high exposure and inadequate distribution to tumors. This technology provides a vehicle for the preferred delivery of existing and approved drugs to tumor environments and local release of the active agent, thereby focusing exposure to tissues in need and reducing unwanted side effects.

Our data-driven platform integrates high-throughput analytics and AI for next-generation drug discovery. We leverage novel insights into the foundational biologic pathways of neurodegenerative diseases to discover, evaluate, and develop disease-modifying therapeutics for Alzheimer’s disease, frontotemporal dementia (FTD) , amyotrophic lateral sclerosis (ALS), and other degenerative diseases of the nervous system.